Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer. Yesterday, June 9, 2015, 89 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $352.00 to $81,483,250.00. Highlighted Stocks Traded by Insiders: Cancer Genetics (CGIX) - FREE Research Report Chaganti Raju S.K., who is Director at Cancer Genetics, sold 24,583 shares at $12.03 on June 9, 2015. Following this transaction, the Director owned 159,394 shares meaning that the stake was reduced by 13.36% with the 24,583-share transaction. The shares most recently traded at $12.07, up $0.04, or 0.35% since the insider transaction. Historical insider transactions for Cancer Genetics go as follows:
4-Week # shares bought: 10,000
12-Week # shares bought: 10,000
24-Week # shares bought: 61,000
The average volume for Cancer Genetics has been 83,400 shares per day over the past 30 days. Cancer Genetics has a market cap of $118.4 million and is part of the health care sector and health services industry. Shares are up 80.39% year-to-date as of the close of trading on Tuesday. Cancer Genetics, Inc., an oncology diagnostics company, focuses on developing and commercializing DNA-based tests and services to enhance and personalize the diagnosis, prognosis, and treatment of targeted cancers in the United States, India, and China. Currently, there are 3 analysts who rate Cancer Genetics a buy, no analysts rate it a sell, and none rate it a hold. Exclusive Offer: Get the latest Stock Analysis on CGIX - FREETheStreet Quant Ratings rates Cancer Genetics as a sell. The company's weaknesses can be seen in multiple areas, such as its deteriorating net income, disappointing return on equity, weak operating cash flow, poor profit margins and feeble growth in its earnings per share. Get the full Cancer Genetics Ratings Report from TheStreet Quant Ratings now. EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.